Mirum Pharmaceuticals, Inc. (MIRM) insider trading

By person

34 insiders · 218 transactions

67.8×

Christopher Peetz holds 67.8 times base salary in stock. $51.25M of shares against $755.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Peetz last reported holding, valued at $90.00, the price Common Stock was last bought or sold at on the open market here, on 4 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Christopher Peetz

Chief Executive Officer

$294.22K (6)

$27.57M (33) scheduled

−$27.28M

581,637

0.8958%

$52.35M

+54.9%

Patrick J Heron

Director

$20.35M (19)

—

+$20.35M

464,713

0.7157%

$41.82M

—

Michael G Grey

Director

—

$12.40M (7) scheduled

−$12.40M

186,410

0.2871%

$16.78M

−33.7%

Jolanda Howe

SVP, Global Controller

—

$9.33M (27) scheduled

−$9.33M

16,728

0.0258%

$1.51M

+845.6%

Novo Holdings A/S entity

10% owner

$8.63M (1)

—

+$8.63M

2,445,147

3.77%

$220.06M

—

Peter J Barris

10% owner

$6.75M (1)

—

+$6.75M

4,186,243

6.45%

$376.76M

—

Forest Baskett

10% owner

$6.75M (1)

—

+$6.75M

1,548

0.0024%

$139.32K

—

Ali Behbahani

10% owner

$6.75M (1)

—

+$6.75M

135

0.0002%

$12.15K

—

Carmen Chang

10% owner

$6.75M (1)

—

+$6.75M

135

0.0002%

$12.15K

—

Anthony A. Florence Jr.

10% owner

$6.75M (1)

—

+$6.75M

11,732

0.0181%

$1.06M

—

Frazier Life Sciences IX, L.P.

10% owner

$6.75M (1)

—

+$6.75M

3,566,912

5.49%

$321.02M

—

Mohamad Makhzoumi

10% owner

$6.75M (1)

—

+$6.75M

11,348

0.0175%

$1.02M

—

Joshua Makower

10% owner

$6.75M (1)

—

+$6.75M

4,186,243

6.45%

$376.76M

—

David M Mott

10% owner

$6.75M (1)

—

+$6.75M

4,186,243

6.45%

$376.76M

—

New Enterprise Associates 16, L.P. entity

10% owner

$6.75M (1)

—

+$6.75M

2,186,243

3.37%

$196.76M

—

Scott D Sandell

10% owner

$6.75M (1)

—

+$6.75M

11,348

0.0175%

$1.02M

—

Peter W. Sonsini

10% owner

$6.75M (1)

—

+$6.75M

4,186,243

6.45%

$376.76M

—

Paul Edward Walker

10% owner

$6.75M (1)

—

+$6.75M

114

0.0002%

$10.26K

—

Peter Radovich

President and COO

—

$3.99M (16)

−$3.99M

57,260

0.0882%

$5.15M

+1,897%

Eric Bjerkholt

Chief Financial Officer

$397.69K (3)

$4.29M (14)

−$3.89M

44,745

0.0689%

$4.03M

+5,996%

Saira Ramasastry

Director

—

$2.42M (13) scheduled

−$2.42M

0.0000%

$0.00

—

Joanne Quan

Chief Medical Officer

—

$1.78M (4)

−$1.78M

18,864

0.0291%

$1.70M

+28,055%

Niall O'Donnell

Director

$4.50M (1)

$5.96M (3)

−$1.46M

1,621,118

2.50%

$145.90M

+1,197%

James E Flynn

10% owner

$4.98M (2)

$3.62M (10)

+$1.36M

1,540,190

2.37%

$138.62M

—

Pamela Vig

Chief Scientific Officer

$17.68K (2)

$1.20M (6) scheduled

−$1.18M

27,406

0.0422%

$2.47M

—

Laura Brege

Director

$112.20K (1)

$1.26M (2) scheduled

−$1.15M

15,703

0.0242%

$1.41M

—

William Fairey

Director

—

$155.09K (1)

−$155.09K

2,500

0.0039%

$225.00K

—

Lara Longpre

Chief Development Officer

$10.27K (1)

$115.69K (5)

−$105.42K

104,407

0.1608%

$9.40M

+39.1%

Ian Clements

Chief Financial Officer

$112.52K (6)

$30.31K (1)

+$82.21K

30,011

0.0462%

$2.70M

+99,937%

Laurent Fischer

Director

$69.02K (6)

—

+$69.02K

10,727

0.0165%

$965.43K

—

Edwin Jonathan Tucker

Chief Medical Officer

$49.56K (2)

$26.26K (1)

+$23.29K

45,838

0.0706%

$4.13M

+2,956%

NEA Partners 16, L.P. entity

10% owner

—

2,186,243

3.37%

$196.76M

−47.8%

Timothy P Walbert

Director

—

9,680

0.0149%

$871.20K

—

Lon Cardon

Director

—

9,680

0.0149%

$871.20K

—

Mirum Pharmaceuticals, Inc.

What the insiders did Net buying

By person